Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This refers to a combination therapy consisting of local anesthetics and corticosteroids administered via supratrochlear and greater occipital nerve block injections. This specific treatment protocol is being evaluated by **Zagazig University** in a randomized controlled trial (NCT06684249) for the management of chronic migraine in adults, comparing its efficacy to Botulinum toxin A (Botox). Local anesthetics work by blocking voltage-gated sodium channels on peripheral sensory nerves to inhibit pain signal transmission, while corticosteroids provide anti-inflammatory effects that may prolong the duration of the analgesic block. The treatment is typically administered once every 12 weeks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on local anesthetics + corticosteroids.